Product Description
Gemifloxacin is used to treat pneumonia. Gemifloxacin may also be used to treat bronchitis but should not be used for this condition if there are other treatment options. Gemifloxacin is in a class of antibiotics called fluoroquinolones. It works by killing bacteria that cause infections. (Sourced from: https://medlineplus.gov/druginfo/meds/a604014.html)
Mechanisms of Action: TOP2 Inhibitor
Novel Mechanism: No
Modality: Small Molecule
Route of Administration: Oral
FDA Designation: *
Approval Status: Approved
Approved Countries: Algeria | Brazil | Canada | Chile | Ecuador | Egypt | India | Jordan | Korea | Malaysia | Mexico | Morocco | New Zealand | Pakistan | Saudi Arabia | South Africa | Taiwan | Tunisia | Turkey | United Arab Emirates
Approved Indications: None
Known Adverse Events: None
Company: None
Company Location:
Company CEO:
Additional Commercial Interests: None
Clinical Description
Countries in Clinic:
Active Clinical Trial Count:
Recent & Upcoming Milestones
Highest Development Phases
Trial ID |
Trial |
Phase |
Trial Status |
Disease |
Primary Completion Date |
Probability of Success |
Latest Trial Update Date |
Data Updated |
|---|
Recent News Events
Date |
Type |
Title |
|---|---|---|
|
12/19/2024 |
News Article |
LG Corp. Chairman and CEO Kwang Mo Koo sends 2025 New Year Address to 270,000 global employees on December 19 |
|
04/12/2023 |
News Article |
Standigm announces Younsung Choo as chief executive officer |
|
06/23/2020 |
News Article |
Legendary Lifestyle Coaching Program Launches Summer Of 2020 With 14-Day Challenge For $1 |
|
06/23/2020 |
News Article |
Legendary Lifestyle Coaching Program Launches Summer Of 2020 With 14-Day Challenge For $1 |